» Articles » PMID: 19960264

Psychosomatic Aspects of Cushing's Syndrome

Overview
Publisher Springer
Specialty Endocrinology
Date 2009 Dec 5
PMID 19960264
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

There has been growing interest in the psychosocial aspects of Cushing's syndrome, such as the role of life stress as a pathogenetic factor, the association with affective disorders, and the presence of residual symptoms after treatment. Interestingly, a temporal relationship between stressful life events and disease onset is relevant only to pituitary-dependent Cushing's disease, and not to the pituitary-independent forms. A number of psychiatric and psychological disturbances may be associated with the active hypercortisolemic state, regardless of its etiology. Within the high frequency of mood disorders (about 60%), major depression is the most common complication. Other psychopathological aspects include mania, anxiety disorders, psychological symptoms (demoralization, irritable mood, somatization) and cognitive impairment. Cognitive symptoms are associated with brain abnormalities (mainly loss of brain volume). Quality of life may be seriously compromised during both active and post-treatment phases. Long-standing hypercortisolism may imply a degree of irreversibility of the pathological process. Recovery, thus, may be delayed and be influenced by highly individualized affective responses. Outcomes of Cushing's syndrome treatment are not fully satisfactory. Within its great complexity, a conceptual shift from a merely biomedical care to a psychosomatic consideration of the person and his/her quality of life appears to be necessary to improve effectiveness. It is time to translate the research evidence that has accumulated into clinical practice initiatives. To patients who show persistence or even worsening of psychological distress upon adequate endocrine treatment psychiatric/psychological interventions should be readily available. Applying interdisciplinary expertise and addressing the needs for rehabilitation would markedly improve final outcome.

Citing Articles

Thyroid Dysfunction and Bipolar Disorder: A Literature Review Integrating Neurochemical, Endocrine, and Genetic Perspectives.

Norman S, Carney A, Algarin F, Witt B, Witzel I, Rodriguez P Cureus. 2024; 16(9):e69182.

PMID: 39398758 PMC: 11468925. DOI: 10.7759/cureus.69182.


Sleep disruption in patients with active and treated endogenous Cushing's syndrome.

Geer E, Grillo I, Li Q, Robins H, Cohen V, Baratz H Pituitary. 2024; 27(5):654-664.

PMID: 39251540 PMC: 11513747. DOI: 10.1007/s11102-024-01450-8.


Mapping Changes in Glutamate with Glutamate-Weighted MRI in Forced Swim Test Model of Depression in Rats.

Lee D, Woo C, Heo H, Ko Y, Jang J, Na S Biomedicines. 2024; 12(2).

PMID: 38397986 PMC: 10887078. DOI: 10.3390/biomedicines12020384.


Risk of dementia and psychiatric or sleep disorders after diagnosis of adrenal adenomas: a population-based cohort study.

Li D, Singh S, Zhang C, Kaur R, Ebbehoj A, Atkinson E Eur J Endocrinol. 2023; 189(4):429-437.

PMID: 37801659 PMC: 10581402. DOI: 10.1093/ejendo/lvad135.


Risk of impulse control disorders in patients with Cushing's disease: do not blame cabergoline but do not give up caution.

Sulu C, Gul N, Tanrikulu S, Ciftci S, Ozturk F, Sarac B Pituitary. 2023; 26(4):495-509.

PMID: 37474846 DOI: 10.1007/s11102-023-01342-3.


References
1.
Armstrong A, Fachnie J . The phenomenology of Cushing's syndrome: one patient's account. Henry Ford Hosp Med J. 1991; 39(1):8-9. View

2.
Lindsay J, Nansel T, Baid S, Gumowski J, Nieman L . Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab. 2005; 91(2):447-53. DOI: 10.1210/jc.2005-1058. View

3.
Sirri L, Grandi S, Fava G . The Illness Attitude Scales. A clinimetric index for assessing hypochondriacal fears and beliefs. Psychother Psychosom. 2008; 77(6):337-50. DOI: 10.1159/000151387. View

4.
Boscaro M, Arnaldi G . Approach to the patient with possible Cushing's syndrome. J Clin Endocrinol Metab. 2009; 94(9):3121-31. DOI: 10.1210/jc.2009-0612. View

5.
Alexandraki K, Kaltsas G, Isidori A, Akker S, Drake W, Chew S . The prevalence and characteristic features of cyclicity and variability in Cushing's disease. Eur J Endocrinol. 2009; 160(6):1011-8. DOI: 10.1530/EJE-09-0046. View